
BlackRock's (BLK) Bitcoin ETF Now Earns More Money than Its Flagship S&P 500 Fund
Don't Miss TipRanks' Half-Year Sale
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Market data shows that the iShares Core S&P 500 ETF (IVV) is trailing the Bitcoin ETF in terms of money generated. While the Bitcoin funds $52 billion in assets under management (AUM) trails the S&P 500 ETF's $624 billion in total assets, the higher fee structure for the Bitcoin fund has turned it into a cash cow for BlackRock.
The IBIT Bitcoin ETF now brings in $187.2 million annually for BlackRock through its 0.25% management fee, while the IVV S&P 500 ETF earns $187.1 million from the 0.03% fee that it charges. The revenue generation is impressive when one considers that the Bitcoin fund only launched in January 2024.
Big Growth
Since its launch, BlackRock's Bitcoin fund has seen inflows every month except one, amassing $52 billion in assets to date. That makes it the largest spot Bitcoin ETF on the market today. The rapid growth of the IBIT fund highlights the strong demand and big growth for regulated crypto investment products, say analysts.
Investors say they like gaining exposure to Bitcoin and other cryptocurrencies without the technical hurdles or security involved in holding the physical asset directly. Although IBIT's management fee is higher than more traditional ETFs, BlackRock says it reflects the added complexity, custody and regulatory requirements involved in offering exposure to cryptocurrencies such as Bitcoin.
Is BLK Stock a Buy?
The stock of BlackRock has a consensus Strong Buy rating among 14 Wall Street analysts. That rating is based on 12 Buy and two Hold recommendations issued in the last three months. The average BLK price target of $1,062.86 implies 0.72% downside from current levels.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Insider
36 minutes ago
- Business Insider
Evercore ISI Remains a Sell on Franklin Resources (BEN)
Evercore ISI analyst Glenn Schorr maintained a Sell rating on Franklin Resources on July 3 and set a price target of $24.00. The company's shares closed last Thursday at $24.88. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Schorr covers the Financial sector, focusing on stocks such as BlackRock, Franklin Resources, and Invesco. According to TipRanks, Schorr has an average return of 10.8% and a 67.08% success rate on recommended stocks. Franklin Resources has an analyst consensus of Hold, with a price target consensus of $21.17, which is a -14.91% downside from current levels. In a report released on July 2, Morgan Stanley also maintained a Sell rating on the stock with a $19.00 price target. Based on Franklin Resources' latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $2.11 billion and a net profit of $151.4 million. In comparison, last year the company earned a revenue of $2.13 billion and had a net profit of $124.2 million Based on the recent corporate insider activity of 45 insiders, corporate insider sentiment is neutral on the stock. Most recently, in April 2025, Charles B. Johnson, a Major Shareholder at BEN sold 420.00 shares for a total of $7,379.40.


Business Insider
36 minutes ago
- Business Insider
Evercore ISI Remains a Buy on Cohen & Steers (CNS)
Evercore ISI analyst John Dunn maintained a Buy rating on Cohen & Steers on July 3 and set a price target of $81.00. The company's shares closed last Thursday at $78.01. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Dunn is a 4-star analyst with an average return of 14.0% and a 56.10% success rate. The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Cohen & Steers with a $67.00 average price target. Based on Cohen & Steers' latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $139.84 million and a net profit of $39.78 million. In comparison, last year the company earned a revenue of $120.48 million and had a net profit of $34 million Based on the recent corporate insider activity of 88 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CNS in relation to earlier this year. Most recently, in May 2025, Jon Cheigh, the President and CIO of CNS sold 25,500.00 shares for a total of $2,040,255.00.


Business Insider
36 minutes ago
- Business Insider
Leerink Partners Remains a Buy on Ardent Health Partners, Inc. (ARDT)
Leerink Partners analyst Whit Mayo reiterated a Buy rating on Ardent Health Partners, Inc. yesterday. The company's shares closed last Thursday at $13.39. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Mayo covers the Healthcare sector, focusing on stocks such as Universal Health, Tenet Healthcare, and UnitedHealth. According to TipRanks, Mayo has an average return of 2.7% and a 49.39% success rate on recommended stocks. Ardent Health Partners, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $21.17, a 58.10% upside from current levels. In a report released on June 20, KeyBanc also maintained a Buy rating on the stock with a $24.00 price target.